High-dose, weekly erlotinib is not an effective treatment in EGFR-mutated non-small cell lung cancer-patients with acquired extracranial progressive disease on standard dose erlotinib.
| Image |  |
|---|---|
| Description | scientific article published on 28 February 2014 |
| Author/s |
author: Pieter E. Postmus Erik Thunnissen |
| Publication date | February 28, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |